Atg4a Antibodies

Santa Cruz Biotechnology provides a broad selection of Atg4a monoclonal antibodies for research in autophagy and cellular homeostasis. Atg4a monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Atg4a, or autophagy-related protein 4A, plays a crucial role in the autophagy process by regulating the lipidation of LC3, which is essential for the formation of autophagosomes. Atg4a is vital for cellular responses to stress and is implicated in various diseases, including neurodegeneration and cancer. Understanding Atg4a function can provide insights into the mechanisms of autophagy and its impact on cellular health. Researchers worldwide utilize Atg4a monoclonal antibodies to investigate cellular degradation pathways and their relationship to disease progression. Advanced research techniques incorporating Atg4a monoclonal antibodies help reveal new aspects of autophagy regulation. Current studies with Atg4a monoclonal antibodies continue to uncover important cellular mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of autophagy and its role in human health.